ID: ALA4094549

Max Phase: Preclinical

Molecular Formula: C13H10N4O2

Molecular Weight: 254.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1cc(-c2c[nH]c3c([N+](=O)[O-])cccc23)ccn1

Standard InChI:  InChI=1S/C13H10N4O2/c14-12-6-8(4-5-15-12)10-7-16-13-9(10)2-1-3-11(13)17(18)19/h1-7,16H,(H2,14,15)

Standard InChI Key:  AOYZBAOTPDCTNT-UHFFFAOYSA-N

Associated Targets(Human)

Nuclear factor of activated T-cells cytoplasmic 1 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycogen synthase kinase-3 beta 11785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dual-specificity tyrosine-phosphorylation regulated kinase 1A 6484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.25Molecular Weight (Monoisotopic): 254.0804AlogP: 2.72#Rotatable Bonds: 2
Polar Surface Area: 97.84Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.60CX Basic pKa: 6.24CX LogP: 2.21CX LogD: 2.18
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.54Np Likeness Score: -0.25

References

1. Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM..  (2017)  Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.,  27  (11): [PMID:28408219] [10.1016/j.bmcl.2017.03.037]

Source